Myeloid Malignancies

Myeloid malignancies are cancers of blood stem cells and bone marrow.

Quick Answer

What it is

Myeloid malignancies are cancers of blood stem cells and bone marrow.

Key findings

No graded findings are available yet.

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

ℹ️ Quick Facts

Quick Facts: Myeloid Malignancies

Supplements Studied:0

0 supps · 0 outcomes

Evidence-Based Protocol

Supplement stack ranked by research quality

Moderate Evidence

Primary Stack (Tier 1)

Vitamin DB

2000-4000 IU daily (monitor levels; target 40-60 ng/mL)

Deficiency common in blood cancers; may support immune function and treatment response; promotes differentiation

15 studies | 1,500 participants

Omega-3 Fatty AcidsB

2-3g EPA+DHA daily

Anti-inflammatory; may support treatment response and reduce inflammation

10 studies | 800 participants

Supporting Stack (Tier 2)

Vitamin CC

500-1000mg daily oral (IV high-dose only in clinical trials)

Supports immune function; high-dose IV studied in AML (TET2 mutations); oral supports general health

8 studies | 400 participants

ZincB

15-30mg daily

Supports immune function; often depleted in cancer patients; important for wound healing

10 studies | 600 participants

ProbioticsC

10-20 billion CFU daily (specific strains for neutropenic patients)

Supports gut health during treatment; may reduce infections; helps with treatment side effects

8 studies | 500 participants

GlutamineB

10-30g daily in divided doses during treatment

May reduce mucositis and support gut barrier during chemotherapy

12 studies | 800 participants

IronB

As directed by hematologist based on iron studies

For iron deficiency anemia (not iron overload); must monitor iron status carefully

15 studies | 1,000 participants

CurcuminC

500-1000mg daily (enhanced absorption formulation)

Anti-inflammatory; studied for potential anti-leukemic effects; may enhance chemotherapy

6 studies | 250 participants

Green Tea Extract (EGCG)C

400-800mg EGCG daily (or 4-6 cups green tea)

Studied for anti-leukemic properties; may support treatment in some contexts

8 studies | 400 participants

How It Works

Myeloid malignancies are blood cancers that arise from myeloid cells in the bone marrow. They include:

•Acute Myeloid Leukemia (AML): Rapidly progressing leukemia requiring urgent treatment

•Myelodysplastic Syndromes (MDS): "Pre-leukemia" conditions with abnormal blood cell production

•Myeloproliferative Neoplasms (MPNs): Including polycythemia vera, essential thrombocythemia, myelofibrosis

•Chronic Myeloid Leukemia (CML): Slower-progressing leukemia (often treated with targeted therapy)

CRITICAL: These are serious cancers requiring expert hematologist/oncologist care. Treatment varies by type and may include chemotherapy, targeted therapy, hypomethylating agents, stem cell transplant, or supportive care. These supplements may support overall health during treatment but are NOT treatments for cancer. ALWAYS discuss supplements with your oncology team - some may interact with chemotherapy or other treatments.

IMPORTANT CONSIDERATIONS:

•Iron: Many patients become iron-overloaded from transfusions - do NOT supplement iron without specific direction from your hematologist

•Antioxidants: Theoretical concern about reducing chemotherapy effectiveness - discuss timing with oncology team

•Neutropenia: When white blood cells are low, infection risk is high - some probiotics may not be safe

•Bleeding risk: Some supplements affect platelets - important when platelet counts are low

* Vitamin D deficiency is common and associated with worse outcomes. Supplementation may support treatment response.

* Omega-3 Fatty Acids have anti-inflammatory effects and may support overall health.

* Zinc supports immune function and wound healing.

* Glutamine may help reduce chemotherapy-related mouth sores (mucositis).

* Probiotics may support gut health but discuss with your team regarding neutropenic precautions.

Expected outcomes: Supplements provide supportive care during treatment. Work closely with your oncology team for appropriate timing and dosing.

Generated from peer-reviewed researchSchema v2.0